JPM vs PRI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
PRI presents a strong fundamental value proposition, characterized by a stable Piotroski F-Score of 4/9 and an exceptional ROE of 31.93%. While the current price of $276.96 trades at a premium to the defensive Graham Number ($199.04), it remains significantly discounted relative to its growth-based intrinsic value of $675.55. The company demonstrates consistent earnings reliability with a high beat rate over 25 quarters and a low P/E ratio (12.09) compared to the financial services sector average. However, the bullish fundamental outlook is tempered by bearish insider sentiment and weak short-term technical trends.
Compare Another Pair
Related Comparisons
JPM vs PRI: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Primerica, Inc. (PRI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.